{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:04:37Z","timestamp":1773151477259,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1016\/s0002-9394(02)01325-9","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T07:46:33Z","timestamp":1027583193000},"page":"552-556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Fomivirsen for the treatment of cytomegalovirus retinitis"],"prefix":"10.1016","volume":"133","author":[{"given":"Douglas A.","family":"Jabs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9394(02)01325-9_BIB1","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9394(14)70789-5","article-title":"AIDS and ophthalmology","volume":"124","author":"Jabs","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB5","first-page":"1931","article-title":"Decline in the rate of specific opportunistic infections at San Francisco, General Hospital, 1994\u20131997","volume":"12","author":"Holtzer","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1086\/313612","article-title":"Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy","volume":"30","author":"Jacobson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/infdis\/172.4.951","article-title":"Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis","volume":"172","author":"Arevalo","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archopht.1996.01100140023002","article-title":"Cytomegalovirus retinitis and viral resistance","volume":"114","author":"Jabs","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB9","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1086\/315851","article-title":"Prevalence of antiviral drug resistance in untreated patients with cytomegalovirus retinitis","volume":"182","author":"Liu","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/514249","article-title":"Cytomegalovirus retinitis and viral resistance","volume":"177","author":"Jabs","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB11","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.42.9.2240","article-title":"Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis","volume":"42","author":"Jabs","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00002030-199806000-00009","article-title":"Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis","volume":"12","author":"Bowen","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0898-953","article-title":"Restoration of cytomegalovirus-specific CD4 + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1","volume":"4","author":"Komanduri","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00002030-199907090-00008","article-title":"Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy","volume":"13","author":"Deayton","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9394(98)00285-2","article-title":"Discontinuing anti-CMV therapy in patients with immune reconstitution after combination antiretroviral therapy","volume":"126","author":"Jabs","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002030-200001280-00013","article-title":"CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy","volume":"14","author":"Torriani","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB17","unstructured":"Jabs DA, Van Natta ML, Kempen JH, et al., for the Studies of Ocular Complications of AIDS Research Group. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol (in press)."},{"key":"10.1016\/S0002-9394(02)01325-9_BIB18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0002-9394(02)01327-2","article-title":"A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS","volume":"133","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0002-9394(02)01326-0","article-title":"Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS","volume":"133","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-9394(02)01332-6","article-title":"Safety of intravenous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS","volume":"133","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/168.3.557","article-title":"A randomized controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS","volume":"168","author":"Spector","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/0003-4819-115-9-665","article-title":"A randomized controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS","volume":"115","author":"Palestine","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-126-4-199702150-00002","article-title":"Parenteral Cidofovir (HPMPC) for treatment of cytomegalovirus retinitis in patients with AIDS: the HPMPC Peripheral Cytomegalovirus Retinitis Trial","volume":"126","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB24","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archopht.1994.01090240037023","article-title":"Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant","volume":"112","author":"Martin","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB25","first-page":"33","article-title":"Retinal detachment in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome","volume":"119","author":"Kempen","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199707103370203","article-title":"Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group","volume":"337","author":"Musch","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB27","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archopht.1996.01100130021004","article-title":"Combination foscarnet and ganciclovir therapy versus monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1086\/314639","article-title":"Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy","volume":"179","author":"Karavellas","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB30","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9394(00)00356-1","article-title":"Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis following highly active antiretroviral therapy","volume":"129","author":"Nguyen","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB31","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0161-6420(94)31181-X","article-title":"Foscarnet-ganciclovir cytomegalovirus retinitis trial","volume":"101","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9394(14)71645-9","volume":"124","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB33","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0161-6420(98)98020-4","article-title":"High-dose (2000 \u03bcg) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis","volume":"105","author":"Young","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/S0002-9394(02)01325-9_BIB34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/bjo.78.2.120","article-title":"High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS","volume":"78","author":"Diaz-Llopis","year":"1994","journal-title":"Br J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939402013259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939402013259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:29:42Z","timestamp":1757593782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939402013259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0002939402013259"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9394(02)01325-9","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fomivirsen for the treatment of cytomegalovirus retinitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9394(02)01325-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}